Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 17/20 | 0.71 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | MGLL | Q99685 | 1/20 | 0.54 |
| ▸ | KIF11 | P52732 | 1/20 | 0.54 |
| ▸ | CNR2 | P34972 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4082541 | 0.86 | MGLL (0.72) | CNR1MGLLKIF11 | |
| SCHEMBL30164935 | 0.86 | MGLL (0.72) | CNR1MGLLKIF11 | |
| SCHEMBL30469269 | 0.83 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL20557298 | 0.83 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL13749770 | 0.83 | KIF11 (0.69) | CNR1NPC1MGLLKIF11 | |
| SCHEMBL8064236 | 0.83 | FGFR3 (0.64) | CNR1MGLLKIF11CNR2 | |
| SCHEMBL14384612 | 0.83 | CNR1 (0.71) | CNR1CNR2 | |
| SCHEMBL28047630 | 0.82 | CFD (0.57) | CNR1MGLLKIF11 | |
| SCHEMBL20557913 | 0.81 | CNR1 (1.00) | CNR1MGLLCNR2 | |
| SCHEMBL30469226 | 0.81 | CNR1 (1.00) | CNR1MGLLCNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090203585-A1 | CAPREOMYCIN DERIVATIVES AND THEIR USE AS ANTIBACTERIALS | ARRAY BIOPHARMA, INC. | 2009-08-13 | — | — | US | disclosed |
| US-20090203585-A1 | CAPREOMYCIN DERIVATIVES AND THEIR USE AS ANTIBACTERIALS | ARRAY BIOPHARMA, INC. | 2009-08-13 | — | — | US | disclosed |
| WO-2007130743-A2 | CAPREOMYCIN DERIVATIVES AND THEIR USE AS ANTIBACTERIALS | ARRAY BIOPHARMA, INC. (US) | 2007-11-15 | — | — | WO | disclosed |
| WO-2007130743-A2 | CAPREOMYCIN DERIVATIVES AND THEIR USE AS ANTIBACTERIALS | ARRAY BIOPHARMA, INC. (US) | 2007-11-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203585-A1 | CAPREOMYCIN DERIVATIVES AND THEIR USE AS ANTIBACTERIALS | CAPRIN1, NISCH, RPIA | CNR1 3790/4885NPC1 305/4885MGLL 3995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.